Source: BioPortfolio

Chiral: Arbor BiosciencesTM Launches Bulk Offerings of CellFree Expression Systems

New myTXTL bulk packagings align with volumes required for highthroughput organizations in synthetic biology. Ann Arbor MI October 1 2019 Arbor BiosciencesTM a division of Chiral Technologies Inc. and leader in developing molecular biology research tools...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Joseph Barendt's photo - President & CEO of Chiral

President & CEO

Joseph Barendt

CEO Approval Rating

70/100

Read more